Contact
QR code for the current URL

Story Box-ID: 257374

Hummingbird Diagnostics GmbH Im Neuenheimer Feld 519 69120 Heidelberg, Germany http://www.hummingbird-diagnostics.com
Contact Ms Eva Sterzel +49 6221 6510300
Company logo of Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH

febit Receives European Patent for Gene Extraction Procedure

(PresseBox) (LEXINGTON, Mass. (USA), and HEIDELBERG, )
febit holding gmbh announced today, that the company has been granted the first European patent (EP1436609) for a microarray-based nucleic acid extraction procedure. In conjunction with the US patent US7320862, febit now holds a unique patent position in the dynamic market of sample preparation for second-generation sequencers.

The new patent refers to a technology that has already been successfully used for a novel method directed at the selection and enrichment of DNA for re-sequencing purposes. This technology substantially enhances the efficiency of high-throughput re-sequencing and renders it suitable for a broad spectrum of applications in medical and biological studies.

Targeted re-sequencing of medically relevant genomic loci enables fundamentally new approaches to research normal cellular functions and pathological changes observed in major diseases such as cancer and Alzheimer's disease. The results of these investigations will allow the development of novel diagnostic tests and provide a greatly enhanced specificity of drug therapies. febit's microfluidic Geniom Biochips have been used successfully for several years in analysis and synthesis of DNA.

febit holds a broad portfolio of 20 granted patents for numerous applications. The first applications for microarray-based extraction procedures were filed back in 2001. Besides bioanalytics, the portfolio predominantly covers biochip-based production of synthetic genes. In this field, febit holds key patents that were successfully used in a recent controversy with a competing U.S. company. Using a focussed application strategy, febit has been able to secure important product components, processes, and advancements.

Hummingbird Diagnostics GmbH

febit develops, produces and markets flexible automated solutions for enabling biochip applications in Life Sciences. febit's product portfolio includes various instruments, optimized assays and bioanalytical services, complemented by bioinformatics software and consulting.

For its main applications - HybSelect, febit's innovative DNA capture method for Next-Generation-Sequencing and protein-coding or non-coding transcriptome profiling - the highly advanced microfluidics of the patented Geniom Biochip offers the highest degree of automation, flexibility and efficiency available.

For more information please visit: www.febit.com

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.